Ifp Advisors, Inc Charles River Laboratories International, Inc. Transaction History

Ifp Advisors, Inc

$3.28 Billion
Q2 2025

A detailed history of Ifp Advisors, Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 4 shares of CRL stock, worth $715. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 223 98.21%

Holding current value

$715

Previous $33,000 100.0%

% of portfolio

0.0%

Previous 0.0%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 24, 2025	SELL	$99.75 - $151.89 $21,845 - $33,263	-219 Reduced 98.21%	4 $0
Q1 2025 May 05, 2025	BUY	$150.52 - $190.14 $602 - $760	4 Added 1.83%	223 $33,000
Q4 2024 Feb 04, 2025	BUY	$178.58 - $220.69 $1,607 - $1,986	9 Added 4.29%	219 $40,000
Q3 2024 Feb 04, 2025	BUY	$187.96 - $245.29 $28,569 - $37,284	152 Added 262.07%	210 $41,000
Q2 2024 Jul 30, 2024	BUY	$206.39 - $268.73 $10,525 - $13,705	51 Added 728.57%	58 $11,000
Q1 2024 Jul 30, 2024	BUY	$203.52 - $273.43 $1,017 - $1,367	5 Added 250.0%	7 $1,000
Q4 2023 Jan 09, 2024	SELL	$164.52 - $238.84 $8,884 - $12,897	-54 Reduced 96.43%	2 $0
Q3 2023 Oct 12, 2023	BUY	$194.44 - $217.61 $8,360 - $9,357	43 Added 330.77%	56 $10,000
Q2 2023 Aug 04, 2023	BUY	$183.71 - $210.25 $1,285 - $1,471	7 Added 116.67%	13 $2,000
Q1 2023 Apr 18, 2023	SELL	$191.89 - $259.92 $67,353 - $91,231	-351 Reduced 98.32%	6 $1,000
Q4 2022 Feb 07, 2023	SELL	$197.11 - $250.07 $474,049 - $601,418	-2,405 Reduced 87.07%	357 $48,000
Q3 2022 Nov 08, 2022	BUY	$182.44 - $250.54 $17,514 - $24,051	96 Added 3.6%	2,762 $329,000
Q2 2022 Sep 06, 2022	BUY	$204.13 - $302.4 $544,210 - $806,198	2,666 New	2,666 $314,000
Q2 2022 Aug 12, 2022	SELL	$204.13 - $302.4 $544,210 - $806,198	-2,666 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$255.51 - $362.11 $339,317 - $480,882	1,328 Added 99.25%	2,666 $757,000
Q1 2022 Aug 08, 2022	BUY	$255.51 - $362.11 $213,095 - $301,999	834 Added 165.48%	1,338 $379,000
Q4 2021 Jan 12, 2022	SELL	$351.38 - $448.68 $47,787 - $61,020	-136 Reduced 21.25%	504 $190,000
Q3 2021 Oct 06, 2021	SELL	$372.64 - $458.3 $12,297 - $15,123	-33 Reduced 4.9%	640 $264,000
Q2 2021 Jul 13, 2021	BUY	$294.17 - $371.65 $6,177 - $7,804	21 Added 3.22%	673 $247,000
Q1 2021 Apr 30, 2021	BUY	$249.67 - $299.48 $9,986 - $11,979	40 Added 6.54%	652 $192,000
Q4 2020 Jan 25, 2021	BUY	$222.0 - $252.62 $55,500 - $63,155	250 Added 69.06%	612 $150,000
Q3 2020 Oct 29, 2020	SELL	$175.56 - $226.45 $4,389 - $5,661	-25 Reduced 6.46%	362 $80,000
Q2 2020 Aug 05, 2020	BUY	$118.84 - $189.72 $713 - $1,138	6 Added 1.57%	387 $65,000
Q1 2020 May 12, 2020	BUY	$98.9 - $178.34 $10,384 - $18,725	105 Added 38.04%	381 $49,000
Q4 2019 Jan 17, 2020	BUY	$126.05 - $152.76 $3,907 - $4,735	31 Added 12.65%	276 $41,000
Q3 2019 Nov 07, 2019	BUY	$125.07 - $143.67 $30,642 - $35,199	245 New	245 $31,000
Q1 2019 May 15, 2019	SELL	$104.82 - $146.73 $16,142 - $22,596	-154 Closed	0 $0
Q4 2018 Jan 23, 2019	BUY	$105.09 - $137.23 $6,935 - $9,057	66 Added 75.0%	154 $17,000
Q3 2018 Oct 25, 2018	BUY	$112.11 - $134.54 $1,345 - $1,614	12 Added 15.79%	88 $0
Q2 2018 Aug 07, 2018	BUY	$102.37 - $117.25 $2,456 - $2,814	24 Added 46.15%	76 $0
Q4 2017 Jan 24, 2018	SELL	$100.43 - $118.09 $50,215 - $59,045	-500 Reduced 90.58%	52 $0
Q3 2017 Oct 30, 2017	BUY	$96.72 - $109.26 $4,642 - $5,244	48 Added 9.52%	552 $60,000
Q4 2016 Jun 03, 2019	SELL	N/A	-44 Reduced 8.03%	504 $38,000
Q2 2016 Jun 03, 2019	BUY	N/A	548	548 $45,000

Others Institutions Holding CRL

# of Institutions

637

Shares Held

52.8M

Call Options Held

1.42M

Put Options Held

1.42M

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account